News & Updates

Patients on antifibrotics experience chest wall dehiscence earlier than those who did not receive antifibrotic treatment following lung transplantation, reveals a recent study, noting that this factor does not significantly influence survival.

In the treatment of patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents appears to yield similar outcomes in terms of the incidence of major adverse cardiac events, the composite safety endpoint, and all-cause mortality, according to the results of the BEST trial.

The use of a cooler dialysate during maintenance haemodialysis does not offer cardiovascular (CV) benefits to patients in the MyTEMP trial.

Children with idiopathic inflammatory myopathies who present with abnormal nailfold capillary changes at baseline are prone to the development of calcinosis, suggests a recent study.

COVID-19 reinfection doubles the risk of death and triples the risk of hospitalization, with post-acute sequelae in the pulmonary and extra-pulmonary organ systems, in a new study.